お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:米国の医療用マリファナ市場 (2021-2027年):市場予測 (用途・投与経路・流通経路別)・産業動向・地域的展望・用途の潜在性・価格動向・市場シェア
市場調査レポート
商品コード
1001592

米国の医療用マリファナ市場 (2021-2027年):市場予測 (用途・投与経路・流通経路別)・産業動向・地域的展望・用途の潜在性・価格動向・市場シェア

U.S. Medical Marijuana Market Size By Application, By Route of Administration,, By Distribution Channel, Industry Analysis Report, Zonal Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 225 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
米国の医療用マリファナ市場 (2021-2027年):市場予測 (用途・投与経路・流通経路別)・産業動向・地域的展望・用途の潜在性・価格動向・市場シェア
出版日: 2021年04月19日
発行: Global Market Insights Inc.
ページ情報: 英文 225 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国の医療用マリファナの市場は、製品の合法化、吐き気、疼痛管理、食欲不振、発作などのさまざまな疾患治療への高い使用率などから、2027年末にかけて力強い成長を遂げると予測されています。

用途別では、吐き気の抑制の部門が2027年末には7億5400万米ドル超の規模に成長する見通しです。また、投与経路別では、経口投与の部門が2020年に21.3%超のシェアを占め、予測期間にわたって急速に成長すると予測されています。

当レポートでは、米国の医療用マリファナの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、市場規模の推移・予測、用途・投与経路・流通経路・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 産業分析

  • 産業の分類
  • 産業情勢
  • 産業への影響要因
    • 成長要因
    • 潜在的リスク&課題
  • 成長の可能性
  • COVID-19:影響分析
  • 規制状況
  • バリューチェーン分析
  • 法的要件
  • ポーターの分析
  • 競合情勢
  • PESTEL分析

第4章 市場分析・予測:用途別

  • 疼痛管理
    • 神経因性疼痛
    • 癌性疼痛
    • その他
  • 筋肉のけいれん
  • 吐き気
  • 食欲不振
  • 発作
  • その他

第5章 市場分析・予測:投与経路別

  • 吸入
  • 経口
  • 局所

第6章 市場分析・予測:流通経路別

  • ディスペンサリー薬局
  • オンライン

第7章 市場分析・予測:地域・州別

第8章 企業プロファイル

  • 競合ダッシュボード
  • Canopy Growth
  • Aphria, Inc.
  • Aurora Cannabis, Inc
  • GW Pharmaceuticals
  • mCig
  • Medical Marijuana Inc.
  • United Cannabis
  • The Supreme Cannabis Company
  • Tilray
  • Emerald Health Therapeutics
  • Lexaria Corporation
  • Cannabis Sativa, Inc.
  • Insys Therapeutics, Inc.
  • Corbus Pharmaceuticals
  • GBSciences, Inc.
  • The Cronos Group
図表

Data Tables

  • TABLE 1 U.S. medical marijuana industry 360 degree synopsis, 2016 - 2027
  • TABLE 2 U.S. medical marijuana market, 2016 - 2020 (USD million)
  • TABLE 3 U.S. medical marijuana market, 2021 - 2027 (USD million)
  • TABLE 4 U.S. medical marijuana market, by application, 2016 - 2020 (USD million)
  • TABLE 5 U.S. medical marijuana market, by application, 2021 - 2027 (USD million)
  • TABLE 6 U.S. medical marijuana market, by route of administration, 2016 - 2020 (USD million)
  • TABLE 7 U.S. medical marijuana market, by route of administration, 2021 - 2027 (USD million)
  • TABLE 8 U.S. medical marijuana market, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 9 U.S. medical marijuana market, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 10 U.S. medical marijuana market, by zone, 2016 - 2020 (USD million)
  • TABLE 11 U.S. medical marijuana market, by zone, 2021 - 2027 (USD million)
  • TABLE 12 Industry impact forces
  • TABLE 13 Pain management market size, by zone, 2016 - 2020 (USD Million)
  • TABLE 14 Pain management market size, by zone, 2021 - 2027 (USD Million)
  • TABLE 15 Neuropathic pain market size, by zone, 2016 - 2020 (USD Million)
  • TABLE 16 Neuropathic pain market size, by zone, 2021 - 2027 (USD Million)
  • TABLE 17 Cancer pain market size, by zone, 2016 - 2020 (USD Million)
  • TABLE 18 Cancer pain market size, by zone, 2021 - 2027 (USD Million)
  • TABLE 19 Others market size, by zone, 2016 - 2020 (USD Million)
  • TABLE 20 Others market size, by zone, 2021 - 2027 (USD Million)
  • TABLE 21 Muscle spasm market size, by zone, 2016 - 2020 (USD Million)
  • TABLE 22 Muscle spasm market size, by zone, 2021 - 2027 (USD Million)
  • TABLE 23 Nausea market size, by zone, 2016 - 2020 (USD Million)
  • TABLE 24 Nausea market size, by zone, 2021 - 2027 (USD Million)
  • TABLE 25 Anorexia market size, by zone, 2016 - 2020 (USD Million)
  • TABLE 26 Anorexia market size, by zone, 2021 - 2027 (USD Million)
  • TABLE 27 Seizures market size, by zone, 2016 - 2020 (USD Million)
  • TABLE 28 Seizures market size, by zone, 2021 - 2027 (USD Million)
  • TABLE 29 Others market size, by zone, 2016 - 2020 (USD Million)
  • TABLE 30 Others market size, by zone, 2021 - 2027 (USD Million)
  • TABLE 31 Inhalation market size, by zone, 2016 - 2020 (USD Million)
  • TABLE 32 Inhalation market size, by zone, 2021 - 2027 (USD Million)
  • TABLE 33 Oral market size, by zone, 2016 - 2020 (USD Million)
  • TABLE 34 Oral market size, by zone, 2021 - 2027 (USD Million)
  • TABLE 35 Topical market size, by zone, 2016 - 2020 (USD Million)
  • TABLE 36 Topical market size, by zone, 2021 - 2027 (USD Million)
  • TABLE 37 Dispensaries market size, by zone, 2016 - 2020 (USD Million)
  • TABLE 38 Dispensaries market size, by zone, 2021 - 2027 (USD Million)
  • TABLE 39 Online market size, by zone, 2016 - 2020 (USD Million)
  • TABLE 40 Online market size, by zone, 2021 - 2027 (USD Million)
  • TABLE 41 North East medical marijuana market size, by states, 2016 - 2020 (USD million)
  • TABLE 42 North East medical marijuana market size, by states, 2021 - 2027 (USD million)
  • TABLE 43 North East medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 44 North East medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 45 North East medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 46 North East medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 47 North East medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 48 North East medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 49 Connecticut medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 50 Connecticut medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 51 Connecticut medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 52 Connecticut medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 53 Connecticut medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 54 Connecticut medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 55 Maine medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 56 Maine medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 57 Maine medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 58 Maine medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 59 Maine medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 60 Maine medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 61 Massachusetts medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 62 Massachusetts medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 63 Massachusetts medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 64 Massachusetts medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 65 Massachusetts medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 66 Massachusetts medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 67 New Hampshire medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 68 New Hampshire medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 69 New Hampshire medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 70 New Hampshire medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 71 New Hampshire medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 72 New Hampshire medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 73 Rhode Island medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 74 Rhode Island medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 75 Rhode Island medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 76 Rhode Island medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 77 Rhode Island medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 78 Rhode Island medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 79 Vermont medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 80 Vermont medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 81 Vermont medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 82 Vermont medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 83 Vermont medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 84 Vermont medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 85 New Jersey medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 86 New Jersey medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 87 New Jersey medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 88 New Jersey medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 89 New Jersey medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 90 New Jersey medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 91 New York medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 92 New York medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 93 New York medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 94 New York medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 95 New York medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 96 New York medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 97 Pennsylvania medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 98 Pennsylvania medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 99 Pennsylvania medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 100 Pennsylvania medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 101 Pennsylvania medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 102 Pennsylvania medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 103 East North Central medical marijuana market size, by states, 2016 - 2020 (USD million)
  • TABLE 104 East North Central medical marijuana market size, by states, 2021 - 2027 (USD million)
  • TABLE 105 East North Central medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 106 East North Central medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 107 East North Central medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 108 East North Central medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 109 East North Central medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 110 East North Central medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 111 Illinois medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 112 Illinois medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 113 Illinois medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 114 Illinois medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 115 Illinois medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 116 Illinois medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 117 Michigan medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 118 Michigan medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 119 Michigan medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 120 Michigan medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 121 Michigan medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 122 Michigan medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 123 West South Central medical marijuana market size, by states, 2016 - 2020 (USD million)
  • TABLE 124 West South Central medical marijuana market size, by states, 2021 - 2027 (USD million)
  • TABLE 125 West South Central medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 126 West South Central medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 127 West South Central medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 128 West South Central medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 129 West South Central medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 130 West South Central medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 131 Ohio medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 132 Ohio medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 133 Ohio medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 134 Ohio medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 135 Ohio medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 136 Ohio medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 137 Arkansas medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 138 Arkansas medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 139 Arkansas medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 140 Arkansas medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 141 Arkansas medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 142 Arkansas medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 143 Oklahoma medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 144 Oklahoma medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 145 Oklahoma medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 146 Oklahoma medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 147 Oklahoma medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 148 Oklahoma medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 149 Louisiana medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 150 Louisiana medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 151 Louisiana medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 152 Louisiana medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 153 Louisiana medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 154 Louisiana medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 155 South Atlantic medical marijuana market size, by states, 2016 - 2020 (USD million)
  • TABLE 156 South Atlantic medical marijuana market size, by states, 2021 - 2027 (USD million)
  • TABLE 157 South Atlantic medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 158 South Atlantic medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 159 South Atlantic medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 160 South Atlantic medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 161 South Atlantic medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 162 South Atlantic medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 163 Delaware medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 164 Delaware medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 165 Delaware medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 166 Delaware medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 167 Delaware medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 168 Delaware medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 169 Florida medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 170 Florida medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 171 Florida medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 172 Florida medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 173 Florida medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 174 Florida medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 175 Maryland medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 176 Maryland medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 177 Maryland medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 178 Maryland medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 179 Maryland medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 180 Maryland medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 181 Washington DC medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 182 Washington DC medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 183 Washington DC medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 184 Washington DC medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 185 Washington DC medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 186 Washington DC medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 187 West North Central medical marijuana market size, by states, 2016 - 2020 (USD million)
  • TABLE 188 West North Central medical marijuana market size, by states, 2021 - 2027 (USD million)
  • TABLE 189 West North Central medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 190 West North Central medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 191 West North Central medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 192 West North Central medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 193 West North Central medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 194 West North Central medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 195 Minnesota medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 196 Minnesota medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 197 Minnesota medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 198 Minnesota medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 199 Minnesota medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 200 Minnesota medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 201 North Dakota medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 202 North Dakota medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 203 North Dakota medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 204 North Dakota medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 205 North Dakota medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 206 North Dakota medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 207 Missouri medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 208 Missouri medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 209 Missouri medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 210 Missouri medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 211 Missouri medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 212 Missouri medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 213 Iowa medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 214 Iowa medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 215 Iowa medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 216 Iowa medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 217 Iowa medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 218 Iowa medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 219 Pacific Central medical marijuana market size, by states, 2016 - 2020 (USD million)
  • TABLE 220 Pacific Central medical marijuana market size, by states, 2021 - 2027 (USD million)
  • TABLE 221 Pacific Central medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 222 Pacific Central medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 223 Pacific Central medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 224 Pacific Central medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 225 Pacific Central medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 226 Pacific Central medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 227 Alaska medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 228 Alaska medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 229 Alaska medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 230 Alaska medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 231 Alaska medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 232 Alaska medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 233 California medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 234 California medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 235 California medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 236 California medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 237 California medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 238 California medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 239 Hawaii medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 240 Hawaii medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 241 Hawaii medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 242 Hawaii medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 243 Hawaii medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 244 Hawaii medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 245 Oregon medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 246 Oregon medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 247 Oregon medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 248 Oregon medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 249 Oregon medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 250 Oregon medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 251 Washington medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 252 Washington medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 253 Washington medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 254 Washington medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 255 Washington medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 256 Washington medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 257 Mountain States medical marijuana market size, by states, 2016 - 2020 (USD million)
  • TABLE 258 Mountain States medical marijuana market size, by states, 2021 - 2027 (USD million)
  • TABLE 259 Mountain States medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 260 Mountain States medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 261 Mountain States medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 262 Mountain States medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 263 Mountain States medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 264 Mountain States medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 265 Arizona medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 266 Arizona medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 267 Arizona medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 268 Arizona medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 269 Arizona medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 270 Arizona medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 271 Colorado medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 272 Colorado medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 273 Colorado medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 274 Colorado medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 275 Colorado medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 276 Colorado medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 277 Nevada medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 278 Nevada medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 279 Nevada medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 280 Nevada medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 281 Nevada medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 282 Nevada medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 283 New Mexico medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 284 New Mexico medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 285 New Mexico medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 286 New Mexico medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 287 New Mexico medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 288 New Mexico medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 289 Montana medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 290 Montana medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 291 Montana medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 292 Montana medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 293 Montana medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 294 Montana medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)
  • TABLE 295 Utah medical marijuana market size, by application, 2016 - 2020 (USD million)
  • TABLE 296 Utah medical marijuana market size, by application, 2021 - 2027 (USD million)
  • TABLE 297 Utah medical marijuana market size, by route of administration, 2016 - 2020 (USD million)
  • TABLE 298 Utah medical marijuana market size, by route of administration, 2021 - 2027 (USD million)
  • TABLE 299 Utah medical marijuana market size, by distribution channel, 2016 - 2020 (USD million)
  • TABLE 300 Utah medical marijuana market size, by distribution channel, 2021 - 2027 (USD million)

Charts & Figures

  • FIG. 1 Top-down approach
  • FIG. 2 Breakdown of primary participants
  • FIG. 3 Medical marijuana industry 360 degree synopsis
  • FIG. 4 Industry segmentation
  • FIG. 5 U.S. medical marijuana market, 2016 - 2027 (USD million)
  • FIG. 6 Growth potential analysis, by application
  • FIG. 7 Growth potential analysis, by route of administration
  • FIG. 8 Growth potential analysis, by distribution channel
  • FIG. 9 Porter's analysis
  • FIG. 10 Company matrix analysis, 2020
  • FIG. 11 PESTEL analysis
  • FIG. 12 Key segment trends, by application
  • FIG. 13 Key segment trends, by route of administration
  • FIG. 14 Key segment trends, by distribution channel
  • FIG. 15 Key zonal trends
  • FIG. 16 Competitive dashboard
目次
Product Code: 2890

Title:
U.S. Medical Marijuana Market Size By Application (Pain Management {Neuropathic Pain, Cancer Pain}, Muscle Spasms, Nausea, Anorexia, Seizures), By Route of Administration, (Inhalation, Oral, Topical), By Distribution Channel (Dispensaries, Online), Industry Analysis Report, Zonal Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027.

The U.S. medical marijuana market is anticipated to witness robust growth by the end of 2027 owing to its legalization and high usage for the treatment of various ailments such as nausea, pain management, anorexia, and seizures among many others.

Today, almost every U.S. state has laws around the use of medical marijuana, in fact, more than two thirds of the states in the U.S., as well as the District of Columbia, have legalized it for medical purposes. Now, ore states are considering to pass bills to do the same thing; as of 14th April 2021, around 17 states, two territories, and the District of Columbia, have passed legislation to legalize cannabis for adult use.

Medical marijuana is basically a plant-based drug, derived from the Cannabis indica or Cannabis sativa species. It contains three main active medicinal compounds, which includes CBN, CBD, and THC. Medical marijuana mainly utilizes the plant or the various marijuana chemicals in it to treat numerous conditions or diseases.

The U.S. medical marijuana market is bifurcated in terms of application, route of administration, distribution channels, and zones.

With respect to application, the overall market is segmented into anorexia, seizures, pain management, nausea, muscle spasms, and others. Nausea segment is expected to reach a valuation of over $754.0 million by the end of 2027. One of the biggest known patient groups, that consume medical marijuana for the suppression vomiting and nausea, are cancer patients that are undergoing chemotherapy treatments.

There are two chemically pure medications that are primarily based on marijuana compounds that have been approved for medical use across the U.S. First, Nabilone or Cesamet® is known as a synthetic cannabinoid that acts like THC. It can usually be taken by mouth to treat nausea as well as vomiting, mainly caused by chemotherapy when other drugs have failed to work.

Second, Dronabinol, which is a gelatin capsule comprising of delta-9-THC (tetrahydrocannabinol) that is FDA approved to treat symptoms of nausea and vomiting caused by poor appetite and weight loss in patients with AIDS and cancer chemotherapy.

With respect to route of administration, the U.S. medical marijuana market is classified into topical, oral, and inhalation. In 2020, the oral route of administration segment accounted for more than 21.3% of the market share, and is forecasted to progress at rapid pace over the projected period.

Based on distribution channel, the U.S. medical marijuana market is divided into online and dispensaries. In 2020, the online segment accounted for more than $2.9 billion valuation, and will witness strong growth through the course of the analysis time period.

In terms of the zones, the South Atlantic zone is projected to witness a CAGR of more than 10.1% over the projected time period attributing to escalating consumer demand.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definitions
  • 1.2 Base estimates & working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 U.S. Medical marijuana industry 360 degree synopsis, 2016-2027
    • 2.1.1 Business trends
    • 2.1.2 Application trends
    • 2.1.3 Route of administration trends
    • 2.1.4 Distribution channel trends
    • 2.1.5 Zonal trends

Chapter 3 US Medical Marijuana Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2016 - 2027
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing application of marijuana for a myriad of medical conditions and symptoms
      • 3.3.1.2 Growing demand for medical marijuana legalization in the U.S.
      • 3.3.1.3 Rising number of R&D and clinical trial activities
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Few side effects might hinder the market growth
      • 3.3.2.2 Difficulty in medical marijuana business banking
  • 3.4 Growth potential analysis
    • 3.4.1 By application
    • 3.4.2 By route of administration
    • 3.4.3 By distribution channel
  • 3.5 COVID-19 impact analysis
  • 3.6 Regulatory landscape
  • 3.7 Value chain analysis
  • 3.8 Legal requirement for distribution of medical marijuana
  • 3.9 Porter's analysis
  • 3.10 Competitive landscape, 2020
    • 3.10.1 Company matrix analysis
  • 3.11 PESTEL analysis

Chapter 4 US Medical Marijuana Market, By Application

  • 4.1 Key segment trends
  • 4.2 Pain Management
    • 4.2.1 Market size, by zone, 2016 - 2027 (USD Million)
    • 4.2.2 Neuropathic pain
      • 4.2.2.1 Market size, by zone, 2016 - 2027 (USD Million)
    • 4.2.3 Cancer pain
      • 4.2.3.1 Market size, by zone, 2016 - 2027 (USD Million)
    • 4.2.4 Others
      • 4.2.4.1 Market size, by zone, 2016 - 2027 (USD Million)
  • 4.3 Muscle spasms
    • 4.3.1 Market size, by zone, 2016 - 2027 (USD Million)
  • 4.4 Nausea
    • 4.4.1 Market size, by zone, 2016 - 2027 (USD Million)
  • 4.5 Anorexia
    • 4.5.1 Market size, by zone, 2016 - 2027 (USD Million)
  • 4.6 Seizures
    • 4.6.1 Market size, by zone, 2016 - 2027 (USD Million)
  • 4.7 Others
    • 4.7.1 Market size, by zone, 2016 - 2027 (USD Million)

Chapter 5 US Medical Marijuana Market, By Route of Administration

  • 5.1 Key segment trends
  • 5.2 Inhalation
    • 5.2.1 Market size, by zone, 2016 - 2027 (USD Million)
  • 5.3 Oral
    • 5.3.1 Market size, by zone, 2016 - 2027 (USD Million)
  • 5.4 Topical
    • 5.4.1 Market size, by zone, 2016 - 2027 (USD Million)

Chapter 6 US Medical Marijuana Market, By Distribution Channel

  • 6.1 Key segment trends
  • 6.2 Dispensaries
    • 6.2.1 Market size, by zone, 2016 - 2027 (USD Million)
  • 6.3 Online
    • 6.3.1 Market size, by zone, 2016 - 2027 (USD Million)

Chapter 7 US Medical Marijuana Market, By Zone

  • 7.1 Key zonal trends
  • 7.2 North East
    • 7.2.1 Market size, by states, 2016 - 2027 (USD Million)
    • 7.2.2 Market size, by application, 2016 - 2027 (USD Million)
      • 7.2.2.1 Market size, by pain management, 2016 - 2027 (USD Million)
    • 7.2.3 Market size, by route of administration, 2016 - 2027 (USD Million)
    • 7.2.4 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.2.5 Connecticut
      • 7.2.5.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.2.5.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.2.5.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.2.5.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.2.6 Maine
      • 7.2.6.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.2.6.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.2.6.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.2.6.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.2.7 Massachusetts
      • 7.2.7.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.2.7.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.2.7.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.2.7.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.2.8 New Hampshire
      • 7.2.8.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.2.8.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.2.8.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.2.8.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.2.9 Rhode Island
      • 7.2.9.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.2.9.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.2.9.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.2.9.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.2.10 Vermont
      • 7.2.10.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.2.10.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.2.10.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.2.10.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.2.11 New Jersey
      • 7.2.11.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.2.11.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.2.11.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.2.11.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.2.12 New York
      • 7.2.12.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.2.12.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.2.12.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.2.12.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.2.13 Pennsylvania
      • 7.2.13.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.2.13.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.2.13.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.2.13.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
  • 7.3 East North Central
    • 7.3.1 Market size, by states, 2016 - 2027 (USD Million)
    • 7.3.2 Market size, by application, 2016 - 2027 (USD Million)
      • 7.3.2.1 Market size, by pain management, 2016 - 2027 (USD Million)
    • 7.3.3 Market size, by route of administration, 2016 - 2027 (USD Million)
    • 7.3.4 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.3.5 Illinois
      • 7.3.5.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.3.5.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.3.5.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.3.5.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.3.6 Michigan
      • 7.3.6.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.3.6.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.3.6.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.3.6.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
  • 7.4 West South Central
    • 7.4.1 Market size, by states, 2016 - 2027 (USD Million)
    • 7.4.2 Market size, by application, 2016 - 2027 (USD Million)
      • 7.4.2.1 Market size, by pain management, 2016 - 2027 (USD Million)
    • 7.4.3 Market size, by route of administration, 2016 - 2027 (USD Million)
    • 7.4.4 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.4.5 Ohio
      • 7.4.5.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.4.5.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.4.5.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.4.5.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.4.6 Arkansas
      • 7.4.6.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.4.6.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.4.6.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.4.6.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.4.7 Oklahoma
      • 7.4.7.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.4.7.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.4.7.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.4.7.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.4.8 Louisiana
      • 7.4.8.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.4.8.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.4.8.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.4.8.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
  • 7.5 South Atlantic
    • 7.5.1 Market size, by states, 2016 - 2027 (USD Million)
    • 7.5.2 Market size, by application, 2016 - 2027 (USD Million)
      • 7.5.2.1 Market size, by pain management, 2016 - 2027 (USD Million)
    • 7.5.3 Market size, by route of administration, 2016 - 2027 (USD Million)
    • 7.5.4 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.5.5 Delaware
      • 7.5.5.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.5.5.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.5.5.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.5.5.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.5.6 Florida
      • 7.5.6.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.5.6.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.5.6.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.5.6.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.5.7 Maryland
      • 7.5.7.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.5.7.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.5.7.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.5.7.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.5.8 Washington DC
      • 7.5.8.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.5.8.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.5.8.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.5.8.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
  • 7.6 West North Central
    • 7.6.1 Market size, by states, 2016 - 2027 (USD Million)
    • 7.6.2 Market size, by application, 2016 - 2027 (USD Million)
      • 7.6.2.1 Market size, by pain management, 2016 - 2027 (USD Million)
    • 7.6.3 Market size, by route of administration, 2016 - 2027 (USD Million)
    • 7.6.4 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.6.5 Minnesota
      • 7.6.5.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.6.5.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.6.5.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.6.5.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.6.6 North Dakota
      • 7.6.6.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.6.6.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.6.6.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.6.6.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.6.7 Missouri
      • 7.6.7.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.6.7.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.6.7.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.6.7.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.6.8 Iowa
      • 7.6.8.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.6.8.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.6.8.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.6.8.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
  • 7.7 Pacific Central
    • 7.7.1 Market size, by states, 2016 - 2027 (USD Million)
    • 7.7.2 Market size, by application, 2016 - 2027 (USD Million)
      • 7.7.2.1 Market size, by pain management, 2016 - 2027 (USD Million)
    • 7.7.3 Market size, by route of administration, 2016 - 2027 (USD Million)
    • 7.7.4 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.7.5 Alaska
      • 7.7.5.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.7.5.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.7.5.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.7.5.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.7.6 California
      • 7.7.6.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.7.6.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.7.6.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.7.6.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.7.7 Hawaii
      • 7.7.7.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.7.7.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.7.7.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.7.7.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.7.8 Oregon
      • 7.7.8.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.7.8.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.7.8.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.7.8.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.7.9 Washington
      • 7.7.9.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.7.9.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.7.9.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.7.9.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
  • 7.8 Mountain States
    • 7.8.1 Market size, by states, 2016 - 2027 (USD Million)
    • 7.8.2 Market size, by application, 2016 - 2027 (USD Million)
      • 7.8.2.1 Market size, by pain management, 2016 - 2027 (USD Million)
    • 7.8.3 Market size, by route of administration, 2016 - 2027 (USD Million)
    • 7.8.4 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.8.5 Arizona
      • 7.8.5.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.8.5.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.8.5.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.8.5.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.8.6 Colorado
      • 7.8.6.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.8.6.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.8.6.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.8.6.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.8.7 Nevada
      • 7.8.7.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.8.7.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.8.7.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.8.7.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.8.8 New Arkansas
      • 7.8.8.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.8.8.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.8.8.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.8.8.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.8.9 Montana
      • 7.8.9.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.8.9.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.8.9.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.8.9.3 Market size, by distribution channel, 2016 - 2027 (USD Million)
    • 7.8.10 Utah
      • 7.8.10.1 Market size, by application, 2016 - 2027 (USD Million)
        • 7.8.10.1.1 Market size, by pain management, 2016 - 2027 (USD Million)
      • 7.8.10.2 Market size, by route of administration, 2016 - 2027 (USD Million)
      • 7.8.10.3 Market size, by distribution channel, 2016 - 2027 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Competitive dashboard, 2020
  • 8.2 Canopy Growth
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 SWOT analysis
  • 8.3 Aphria, Inc.
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 SWOT analysis
  • 8.4 Aurora Cannabis, Inc
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 SWOT analysis
  • 8.5 GW Pharmaceuticals
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 SWOT analysis
  • 8.6 mCig
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 SWOT analysis
  • 8.7 Medical Marijuana Inc.
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 SWOT analysis
  • 8.8 United Cannabis
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 SWOT analysis
  • 8.9 The Supreme Cannabis Company
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 SWOT analysis
  • 8.10 Tilray
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 SWOT analysis
  • 8.11 Emerald Health Therapeutics
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 SWOT analysis
  • 8.12 Lexaria Corporation
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Product landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 SWOT analysis
  • 8.13 Cannabis Sativa, Inc.
    • 8.13.1 Business overview
    • 8.13.2 Financial data
    • 8.13.3 Product landscape
    • 8.13.4 Strategic outlook
    • 8.13.5 SWOT analysis
  • 8.14 Insys Therapeutics, Inc.
    • 8.14.1 Business overview
    • 8.14.2 Financial data
    • 8.14.3 Product landscape
    • 8.14.4 Strategic outlook
    • 8.14.5 SWOT analysis
  • 8.15 Corbus Pharmaceuticals
    • 8.15.1 Business overview
    • 8.15.2 Financial data
    • 8.15.3 Product landscape
    • 8.15.4 Strategic outlook
    • 8.15.5 SWOT analysis
  • 8.16 GBSciences, Inc.
    • 8.16.1 Business overview
    • 8.16.2 Financial data
    • 8.16.3 Product landscape
    • 8.16.4 Strategic outlook
    • 8.16.5 SWOT analysis
  • 8.17 The Cronos Group
    • 8.17.1 Business overview
    • 8.17.2 Financial data
    • 8.17.3 Product landscape
    • 8.17.4 Strategic outlook
    • 8.17.5 SWOT analysis
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.